Electrical stimulation devices market is expected to reach US$ 11,334.0 million by 2027 and it is estimated to grow at a CAGR of 9.3% during 2020–2027.
Medtronic Receives Approval for U.S. Labeling of the Intellis Platform Showing Superior Back Pain Relief When Using DTM Spinal Cord Stimulation
Medtronic plc the global leader in medical technology, today announced the U.S. Food and Drug Administration has approved revised commercial labeling for the Intellis™ Platform with Differential Target Multiplexed programming for the treatment of chronic, intractable back and leg pain. The new labeling will include study outcomes from a multicenter randomized control trial reflecting superior back pain relief with …
Medtronic plc (NYSE: MDT), the global leader in medical technology, today announced the U.S. Food and Drug Administration (FDA) has approved revised commercial labeling for the Intellis™ Platform with Differential Target Multiplexed (DTM™) programming for the treatment of chronic, intractable back and leg pain. The new labeling will include study outcomes from a multicenter randomized control trial reflecting superior ba